Showing results (981-990 of 1,104) with videos related to

Sort By:
Pageof 111
Leukemia Research|November 8, 2021
MYC overexpression is associated with an early disease progression from MDS to AMLDavid Gajzer, Constantine N Logothetis, David A Sallman, et al.
Scientific Reports|June 18, 2020
Assessment of Luminal and Basal Phenotypes in Bladder CancerCharles C Guo, Jolanta Bondaruk, Hui Yao, et al.
Endocrine-Related Cancer|September 26, 2024
Body composition in recurrent prostate cancer and the role of steroidogenic genotypeNeha Venkatesh, Rebecca S Tidwell, Yao Yu, et al.
Prostate Cancer and Prostatic Diseases|September 13, 2022
Characterization of prostate cancer adrenal metastases: dependence upon androgen receptor signaling and steroid hormonesMinas J Sakellakis, Andrew W Hahn, Sumankalai Ramachandran, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 23, 2004
Evidence that transfer of functional p53 protein results in increased apoptosis in prostate cancerLouis L Pisters, Curtis A Pettaway, Patricia Troncoso, et al.
European Journal of Cancer (Oxford, England : 1990)|January 28, 2020
A candidate androgen signalling signature predictive of response to abiraterone acetate in men with metastatic castration-resistant prostate cancerMyrto Boukovala, Nicholas Spetsieris, Justin A Weldon, et al.
Urology|May 10, 2025
GLP-1 Agonist Use Among Men With Localized Prostate Cancer: A Narrative Review and Rationale for Prospective Clinical TrialsAndrew Fang, Daniel E Frigo, Andrew Hahn, et al.
The Lancet. Oncology|December 3, 2014
Personalised chemotherapy based on tumour marker decline in poor prognosis germ-cell tumours (GETUG 13): a phase 3, multicentre, randomised trialKarim Fizazi, Lance Pagliaro, Agnes Laplanche, et al.
Oncogene|September 29, 2021
Prostate cancer castrate resistant progression usage of non-canonical androgen receptor signaling and ketone body fuelEstefania Labanca, Juan Bizzotto, Pablo Sanchis, et al.
Journal of the National Cancer Institute|February 27, 2009
Selenium and vitamin E: cell type- and intervention-specific tissue effects in prostate cancerDimitra Tsavachidou, Timothy J McDonnell, Sijin Wen, et al.
Pageof 111